Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the HOST-EXAM Trial.

ABSTRACT:

Importance

Selecting the optimal antiplatelet agent in patients who have received percutaneous coronary intervention is especially important in those with diabetes due to the heightened risk of ischemic events in this population. Studies on the efficacy and safety of clopidogrel vs aspirin for long-term maintenance after percutaneous coronary intervention in patients with diabetes are lacking.

Objective

To investigate cardiovascular outcomes with clopidogrel vs aspirin in patients with and without diabetes.

Design, setting, and participants

This was a post hoc analysis of the HOST-EXAM randomized clinical trial, an investigator-initiated, prospective, randomized, open-label, multicenter trial performed at 37 centers in Korea. Patients who received dual antiplatelet th

SUBMITTER: Rhee TM 

PROVIDER: S-EPMC10099092 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature